API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 2 sources · 28 days · First seen · Last updated

Pharmaceutical companies sponsoring Formula 1 teams

Overview

Pharmaceutical companies have entered into multi-year agreements to partner with Formula 1 teams.

In October 2026, AbbVie announced it would become the official pharmaceutical partner of the McLaren Mastercard Formula 1 team. Through its ‘Race to Innovate’ program, AbbVie committed to donating $10,000 for every 10 points McLaren earns in the Constructors' Championship to support charities and patient advocacy groups for autoimmune and immune-mediated diseases. This partnership was scheduled to debut at the United States Grand Prix.

In November 2026, Viatris Inc. announced a multi-year agreement to become the official global pharmaceutical partner of the Cadillac Formula 1 Team. This collaboration is set to begin with the 2027 Formula 1 season, aiming to increase brand visibility for Viatris while expanding the commercial ecosystem for the Cadillac team as it prepares for its 2026 debut.

Entities

Viatris Inc. · AbbVie · Fishers, Indiana · McLaren · Formula 1

Timeline

  1. [BUSINESS] 2 sources
    Viatris named official global pharmaceutical partner of Cadillac F1 Team

    Viatris Inc. has signed a multi-year deal to become the official global pharmaceutical partner of the Cadillac Formula 1 Team, starting in 2027.

  2. [BUSINESS] 2 sources
    AbbVie and McLaren announce Formula 1 partnership

    AbbVie has signed a multi-year deal to become the official pharmaceutical partner of the McLaren Formula 1 team, pledging donations to autoimmune disease charities based on team performance.

Sources

pressreach.com · sportsmintmedia.com